Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized, placebo-controlled phase 2 trial

Saved in:

Bibliographic Details
Main Authors:	Yanling Wu, Yuan Li, Ping Zhang, Siwei Guo, Fang Yuan, Vivian Liu, Ting Yu, Feng Lin, Nan Yang, Chao Tu, Hongzhou Lu, Tianlei Ying, Xin Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-07-01
Series:	Cell Discovery
Online Access:	https://doi.org/10.1038/s41421-025-00813-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet